The relevance of these FTD panels is additionally supported by the association of some markers (e.g., MMP10, PLTP, PRDX1, and NPDC1) with clinical parameters such as cognitive functioning or disease severity. The gene discussed is PRDX1; the disease is frontotemporal dementia.